The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 17, 2008

Filed:

Mar. 04, 2006
Applicants:

Victor Matvienko, Donetak, UA;

Alexey Matvyeyev, Donetak, UA;

Alexander F. Zabudkin, Donetak, UA;

Aleksandr M. Itkin, San Diego, CA (US);

Inventors:

Victor Matvienko, Donetak, UA;

Alexey Matvyeyev, Donetak, UA;

Alexander F. Zabudkin, Donetak, UA;

Aleksandr M. Itkin, San Diego, CA (US);

Assignee:

Solux Corporation, San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 15/24 (2006.01);
U.S. Cl.
CPC ...
Abstract

A method of synthesizing R1, R2-substituted-4' (ax. or eq.)-OH anthracyclines and their corresponding salts of Formula (1) from daunorubicin or N-Trifluoroacetyl-4-R1-derivatives of daunorubicin, wherein R1 is defined as H, OH, and 4′-HO is defined as ax[ial]. The method includes producing N-Trifluoroacetyl daunorubicin and treating the N-Trifluoroacetyldaunorubicin or N-Trifluoroacetyl-4-R-derivatives of daunorubicin, wherein Ris defined as H, OH, with dimethylsulfoxide activated by different acylating agents. The attained intermediate product is then treated with a strong base (ex. tertiary amines) resulting in the 4′-keto-N-Trifluoroacetyl-4-Rdaunorubicin wherein Ris defined as H, OH, OMe. The 4′-keto-N-Trifluoroacetyl-4-R-daunorubicin is reacted with a reducing agent, a derivative of a borohydride of an alkaline metal MHBL, to produce N-Trifluoroacetyl-4′-epi-4-R-daunorubicin. The N-Trifluoroacetyl-4′-epi-4-R-daunorubicin undergoes hydrolysis in a basic solution to produce a derivate of an anthoacyclin which is halogenized [by complex halogenides] to form a 14-Hal-derivative. This result is then hydrolyzed by well-known methods in the presence of a formate of an alkaline metal to form the desired final compound.


Find Patent Forward Citations

Loading…